Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Protein Complexes with Interchangeable Parts01:57

Protein Complexes with Interchangeable Parts

Groups of proteins may form a complex where each protein in this complex has a different role in the overall execution of the complex’s function. Often some of the proteins in the complex can be replaced by a closely related variant to give a complex that contains many of the same components yet is functionally distinct.
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order to...
Protein Complexes with Interchangeable Parts01:57

Protein Complexes with Interchangeable Parts

Groups of proteins may form a complex where each protein in this complex has a different role in the overall execution of the complex’s function. Often some of the proteins in the complex can be replaced by a closely related variant to give a complex that contains many of the same components yet is functionally distinct.
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order to...
Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence01:19

Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence

Pharmaceutical products contain more than just the active drug; they also contain various excipients such as binders, solubilizers, stabilizers, preservatives, and other elements. In some cases, impurities or contaminants might be present. Traditionally, quality control in pharmaceuticals has primarily focused on the analysis of the active drug, often overlooking the impact of these additional components. The recent issue with heparin contamination by over-sulfated chondroitin sulfate, a...
Glucagon-like Receptor Agonists01:24

Glucagon-like Receptor Agonists

Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
Taste Buds and Receptors01:20

Taste Buds and Receptors

Gustation, or the sense of taste, is intrinsically linked to the anatomical structures located on the tongue. This organ's surface, along with the entirety of the oral cavity, is adorned with stratified squamous epithelium. Evident on the tongue are elevated structures known as papillae (singular = papilla), which house the mechanisms for the transduction of gustatory stimuli. Four distinct types of papillae exist, each identified by their unique morphological attributes: the circumvallate,...
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence01:27

Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence

Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nutritional Influences on the Brain in ADHD: Evidence from Neuroimaging Studies.

Neurology international·2026
Same author

Wqsreg: a Stata command for weighted quantile sum regression.

European journal of epidemiology·2026
Same author

Fatigue after critical illness: prevalence, trajectories, and longitudinal associations in a multicenter ICU survivor follow-up program.

Critical care (London, England)·2026
Same author

Fermentation in breadmaking: enhancing digestibility and nutritional value for gastrointestinal health.

Frontiers in nutrition·2026
Same author

Genotoxic Damage and microRNA Dysregulation in Firefighters: An Integrated Biomonitoring Case Study.

Journal of xenobiotics·2026
Same author

LIFETIME JEM-DERIVED OCCUPATIONAL EXPOSURE BURDEN AND ODDS OF PARKINSON'S DISEASE AND PARKINSONISM IN A MATCHED CASE-CONTROL STUDY.

medRxiv : the preprint server for health sciences·2026
Same journal

Food-Derived Peptides: Neuropeptides and the Diet-Microbiome-Brain Axis.

Annual review of food science and technology·2026
Same journal

Alternatives to the Vegetable Oil Hydrogenation Process to Reduce <i>Trans</i>-Fatty Acids.

Annual review of food science and technology·2026
Same journal

Aquaculture for Sustainable Human Dietary Protein.

Annual review of food science and technology·2026
Same journal

Synthetic Biology Approaches in Reducing Mycotoxin Contamination and Enhancing Food System Sustainability.

Annual review of food science and technology·2026
Same journal

Sustainable Processing in Food Manufacturing.

Annual review of food science and technology·2026
Same journal

Predicting Fiber Specificity on Gut Microbiome Modulation.

Annual review of food science and technology·2026
See all related articles

Related Experiment Video

Updated: May 24, 2026

Film Extrusion of Crambe abyssinica/Wheat Gluten Blends
06:51

Film Extrusion of Crambe abyssinica/Wheat Gluten Blends

Published on: January 17, 2017

Functional replacements for gluten.

Emanuele Zannini1, Julie Miller Jones, Stefano Renzetti

  • 1School of Food and Nutrition Sciences, University College Cork, County Cork, Ireland.

Annual Review of Food Science and Technology
|March 6, 2012
PubMed
Summary
This summary is machine-generated.

Celiac disease (CD) requires a strict gluten-free diet, posing baking challenges. This review explores advances in gluten-free bread formulation using alternative ingredients and technologies.

More Related Videos

Composition and Properties of Aquafaba: Water Recovered from Commercially Canned Chickpeas
10:35

Composition and Properties of Aquafaba: Water Recovered from Commercially Canned Chickpeas

Published on: February 10, 2018

Techniques for the Evolution of Robust Pentose-fermenting Yeast for Bioconversion of Lignocellulose to Ethanol
14:53

Techniques for the Evolution of Robust Pentose-fermenting Yeast for Bioconversion of Lignocellulose to Ethanol

Published on: October 24, 2016

Related Experiment Videos

Last Updated: May 24, 2026

Film Extrusion of Crambe abyssinica/Wheat Gluten Blends
06:51

Film Extrusion of Crambe abyssinica/Wheat Gluten Blends

Published on: January 17, 2017

Composition and Properties of Aquafaba: Water Recovered from Commercially Canned Chickpeas
10:35

Composition and Properties of Aquafaba: Water Recovered from Commercially Canned Chickpeas

Published on: February 10, 2018

Techniques for the Evolution of Robust Pentose-fermenting Yeast for Bioconversion of Lignocellulose to Ethanol
14:53

Techniques for the Evolution of Robust Pentose-fermenting Yeast for Bioconversion of Lignocellulose to Ethanol

Published on: October 24, 2016

Area of Science:

  • Gastroenterology and Food Science

Background:

  • Celiac disease (CD) is an immune-mediated disorder triggered by gluten ingestion in susceptible individuals.
  • A strict, lifelong gluten-free (GF) diet is the only effective therapy for managing CD.
  • Gluten's unique properties present significant challenges in creating high-quality GF baked goods.

Purpose of the Study:

  • To review the fundamentals of celiac disease, including its prevalence.
  • To discuss recent advancements in producing high-quality gluten-free breads.
  • To highlight the use of alternative ingredients and technologies in GF baking.

Main Methods:

  • Literature review of celiac disease basics and prevalence.
  • Analysis of recent research on gluten-free bread preparation techniques.
  • Examination of novel ingredients and technologies for GF baking.

Main Results:

  • Gluten-free flours, starches, hydrocolloids, and gums are key components in GF bread formulation.
  • Novel functional ingredients and advanced processing technologies are improving GF bread quality.
  • Understanding ingredient interactions is crucial for successful GF product development.

Conclusions:

  • Advances in food science offer promising solutions for improving gluten-free bread quality.
  • Continued research into alternative ingredients and technologies is vital for meeting the needs of celiac patients.
  • Developing palatable and nutritious GF options remains an important goal in dietary management of CD.